Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Constellation Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Constellation Pharmaceuticals (United States)

Cambridgecompany

305

Works

83,401

Citations

148

h-index

Top Research Topics

Protein Degradation and Inhibitors Epigenetics and DNA Methylation Multiple Myeloma Research and Treatments

Top Researchers

Alex R. Chang Geisinger Health System

444 works76,328 citationsh-index: 61

Recent Research

Reply to Comments for ‘Appraisal of <scp>AI</scp> ‐Based Fibrosis Quantification in <scp>MASH</scp> ’

Kutbuddin Akbary,Mazen Noureddin,et al.

20250 citations

Cancer-related gene regulation

Myeloproliferative Neoplasms: Diagnosis and Treatment

Histone Deacetylase Inhibitors Research

Chronic Myeloid Leukemia Treatments

Genomics and Chromatin Dynamics

Ubiquitin and proteasome pathways

Chronic Lymphocytic Leukemia Research

RNA modifications and cancer

Cancer Genomics and Diagnostics

J. J. Beatty The Ohio State University

981 works63,816 citationsh-index: 108

G. Tarlé Hiroshima Shudo University

1,202 works45,481 citationsh-index: 101

Richard D. Cummings Beth Israel Deaconess Medical Center

679 works44,527 citationsh-index: 106

Jing Wang National Institute of Biological Sciences, Beijing

1,198 works34,404 citationsh-index: 85

Zehua Chen Tulane University

277 works32,682 citationsh-index: 39

Development of <scp>AI</scp> Based Fibrosis Detection Algorithm by <scp>SHG</scp> / <scp>TPEF</scp> Microscopy for Fully Quantified Liver Fibrosis Assessment in <scp>MASH</scp>

Kutbuddin Akbary,Mazen Noureddin,et al.

20258 citations

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Raajit K. Rampal,Sebastian Grosicki,et al.

202526 citations

Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naïve Patients with Myelofibrosis

John Mascarenhas,Sebastian Grosicki,et al.

20246 citations

Targeting Aberrant <i>DLK1</i> Re-Expression in <i>ASXL1</i>-Mutant Chronic Myelomonocytic Leukemia with BRD4 / p300-Directed Epigenetic Small Molecule Therapy

Terra L. Lasho,Jenna Fernandez,et al.

20240 citations

Pelabresib Plus Ruxolitinib Combination Therapy in JAK Inhibitor-Naïve Patients With Myelofibrosis in the Phase 3 MANIFEST-2 Study: Preliminary Evidence of Bone Marrow Recovery

John Mascarenhas,Raajit K. Rampal,et al.

20240 citations